This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
P3‐020: AXS‐05, A NOVEL ORAL NMDA RECEPTOR ANTAGONIST WITH MULTI‐MODAL ACTIVITY IN CLINICAL DEVELOPMENT FOR AGITATION ASSOCIATED WITH ALZHEIMER'S DISEASE. (1st July 2019)
Record Type:
Journal Article
Title:
P3‐020: AXS‐05, A NOVEL ORAL NMDA RECEPTOR ANTAGONIST WITH MULTI‐MODAL ACTIVITY IN CLINICAL DEVELOPMENT FOR AGITATION ASSOCIATED WITH ALZHEIMER'S DISEASE. (1st July 2019)
Main Title:
P3‐020: AXS‐05, A NOVEL ORAL NMDA RECEPTOR ANTAGONIST WITH MULTI‐MODAL ACTIVITY IN CLINICAL DEVELOPMENT FOR AGITATION ASSOCIATED WITH ALZHEIMER'S DISEASE